2-oxindole has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, P; Lv, Y; Wang, S; Zhang, G; Zhang, N; Zhao, Y | 1 |
| Jeyaveeran, JC; Parthasarathy, K; Praveen, C; Prince, AA | 1 |
2 other study(ies) available for 2-oxindole and Colonic Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Fibroblasts; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Lung Neoplasms; Pyrroles; Sunitinib; Thiazolidines | 2011 |
Gold catalyzed double condensation reaction: Synthesis, antimicrobial and cytotoxicity of spirooxindole derivatives.
Topics: Anti-Infective Agents; Bacteria; Binding Sites; Catalysis; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Colonic Neoplasms; Coumarins; Gold; Humans; Hydrogen Bonding; Indoles; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Docking Simulation; Molecular Structure; Oxindoles; Spiro Compounds | 2016 |